{"transactions":[{"id":680364,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":false,"shares":573,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":164.3,"exercise_date":"2021-03-02","expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":573},"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":680363,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":573,"price":285.24,"value":163442.52,"ownership":{"direct":true},"balance_after":1438,"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":680362,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-08-20T20:31:03.000Z","date":"2026-08-18","kind":"exercise","planned":false,"acquired":true,"shares":573,"price":164.3,"value":94143.9,"ownership":{"direct":true},"balance_after":2011,"source":{"system":"sec-edgar","filing":"0001100682-26-000134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000134/form4.xml","form_type":"4"}},{"id":743247,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:23:47.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest and be fully exercisable on the earlier of (i) the date of the issuer's 2027 annual stockholders meeting or (ii) June 8, 2027, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":18000,"derivative":{"exercise_price":23.58,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001804999-26-000002","document":"form4-06102026_080643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804999/000180499926000002/form4-06102026_080643.xml","form_type":"4"}},{"id":779676,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-14T21:11:40.000Z","date":"2026-05-12","kind":"gift","planned":false,"acquired":true,"shares":3964,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":3964,"source":{"system":"sec-edgar","filing":"0001100682-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000073/form4.xml","form_type":"4"}},{"id":779675,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-14T21:11:40.000Z","date":"2026-05-12","kind":"gift","planned":false,"acquired":false,"shares":3964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 3,964 shares held by the reporting person to a revocable trust controlled by the reporting person."}],"balance_after":1438,"source":{"system":"sec-edgar","filing":"0001100682-26-000073","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000073/form4.xml","form_type":"4"}},{"id":785212,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-11T20:45:56.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1438,"price":177.62,"value":255417.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/8/2027 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":5402,"source":{"system":"sec-edgar","filing":"0001100682-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000057/form4.xml","form_type":"4"}},{"id":1033095,"issuer":{"id":1775,"kind":"organization","name":"Maze Therapeutics, Inc.","symbol":"MAZE"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-09-24T20:13:08.000Z","date":"2025-09-22","kind":"grant","planned":false,"acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 1/9 of the total award monthly with the first tranche vesting on October 1, 2025, subject to the reporting person's continued service to the Issuer on the applicable vesting date."}],"balance_after":18000,"derivative":{"exercise_price":23.67,"expiration_date":"2035-09-21","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001804999-25-000005","document":"form4-09242025_080904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1804999/000180499925000005/form4-09242025_080904.xml","form_type":"4"}},{"id":1135840,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-23T20:08:31.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":2076,"price":134.98,"value":280218.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The stock options become exercisable upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2076,"derivative":{"exercise_price":134.98,"exercise_date":"2026-05-21","expiration_date":"2035-05-21","underlying":"Common Stock","underlying_shares":2076},"source":{"system":"sec-edgar","filing":"0001127602-25-015469","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015469/form4.xml","form_type":"4"}},{"id":1135839,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-23T20:08:31.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":946,"price":134.98,"value":127691.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/21/2026 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":3964,"source":{"system":"sec-edgar","filing":"0001127602-25-015469","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760225015469/form4.xml","form_type":"4"}},{"id":1516350,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2024-05-15T23:24:16.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":1311,"price":228.41,"value":299445.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1311,"derivative":{"exercise_price":228.41,"exercise_date":"2025-05-13","expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":1311},"source":{"system":"sec-edgar","filing":"0001127602-24-015536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224015536/form4.xml","form_type":"4"}},{"id":1516349,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-05-15T23:24:16.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":559,"price":228.41,"value":127681.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders"}],"balance_after":3018,"source":{"system":"sec-edgar","filing":"0001127602-24-015536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224015536/form4.xml","form_type":"4"}},{"id":1889708,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-17T18:11:16.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":1669,"price":192.36,"value":321048.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1669,"derivative":{"exercise_price":192.36,"exercise_date":"2024-05-15","expiration_date":"2033-05-15","underlying":"Common Stock","underlying_shares":1669},"source":{"system":"sec-edgar","filing":"0001127602-23-015839","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015839/form4.xml","form_type":"4"}},{"id":1889707,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-17T18:11:16.000Z","date":"2023-05-15","kind":"grant","planned":false,"acquired":true,"shares":664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/15/2024 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2459,"source":{"system":"sec-edgar","filing":"0001127602-23-015839","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223015839/form4.xml","form_type":"4"}},{"id":2272407,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2022-05-13T20:03:43.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":1582,"price":222.31,"value":351694.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1582,"derivative":{"exercise_price":222.31,"exercise_date":"2023-05-11","expiration_date":"2022-05-12","underlying":"Common Stock","underlying_shares":1582},"source":{"system":"sec-edgar","filing":"0001127602-22-014388","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222014388/form4.xml","form_type":"4"}},{"id":2272406,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-13T20:03:43.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":575,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/11/2023 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1795,"source":{"system":"sec-edgar","filing":"0001127602-22-014388","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222014388/form4.xml","form_type":"4"}},{"id":2721334,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2021-05-10T21:16:10.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":1151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1151,"derivative":{"exercise_price":342.55,"exercise_date":"2022-05-07","expiration_date":"2031-05-07","underlying":"Common Stock","underlying_shares":1151},"source":{"system":"sec-edgar","filing":"0001127602-21-016096","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221016096/form4.xml","form_type":"4"}},{"id":2721333,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-10T21:16:10.000Z","date":"2021-05-07","kind":"grant","acquired":true,"shares":355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/7/2022 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":1220,"source":{"system":"sec-edgar","filing":"0001127602-21-016096","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221016096/form4.xml","form_type":"4"}},{"id":3153081,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-12T18:33:24.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":2539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Options become exercisable upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":2539,"derivative":{"exercise_price":164.24,"exercise_date":"2021-05-11","expiration_date":"2030-05-11","underlying":"Common Stock","underlying_shares":2539},"source":{"system":"sec-edgar","filing":"0001127602-20-016265","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220016265/form4.xml","form_type":"4"}},{"id":3153080,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-05-12T18:33:24.000Z","date":"2020-05-11","kind":"grant","acquired":true,"shares":741,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The unvested restricted stock units vest upon the earlier of 5/11/2021 or the business day prior to the Company's next annual meeting of shareholders."}],"balance_after":865,"source":{"system":"sec-edgar","filing":"0001127602-20-016265","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220016265/form4.xml","form_type":"4"}},{"id":3228291,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-04T21:51:04.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":573,"price":164.3,"value":94143.9,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options become exercisable one year from the date of grant."}],"balance_after":573,"derivative":{"exercise_price":164.3,"exercise_date":"2021-03-02","expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":573},"source":{"system":"sec-edgar","filing":"0001127602-20-009452","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009452/form4.xml","form_type":"4"}},{"id":3228290,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":21332,"kind":"person","name":"Andrews Nancy C","position":1,"cik":"0001804999","reported_name":"Andrews Nancy C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-03-04T21:51:04.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of 124 unvested restricted stock units that vest on 3/02/2021."}],"balance_after":124,"source":{"system":"sec-edgar","filing":"0001127602-20-009452","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009452/form4.xml","form_type":"4"}}]}